| Specifications | FDA LACF Inspection Report FORM FDA-3511 PSC Graphics |
| Business section |

| Specifications | FDA LACF Inspection Report FORM FDA-3511 PSC Graphics |
| Business section |

| Specifications | FDA LACF Inspection Report FORM FDA-3511 PSC Graphics |
| Suggested Link Details/Purchase | |
| Content | FORM FDA 3511 (7/10)PAGE 1 of 15 Firm Name, City & State: Inspection Date(s): Investigators: FEI Number: FCE Number: FDA LACF INSPECTION REPORT DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION PSC Graphics (301) 443-1090 EF This inspection report is available in PDF on the forms site: http://www.fda.gov/opacom/morechoices/ fdaforms/ora. html. Narrative responses to each item can be entered in the item’s “comments” area or where otherwise prompted. Complete documentation of deficiencies, including deviations from Part 113, should be narrated with reference to photos, exhibits, etc., in the Turbo EIR under “Objectionable Conditions and Management’s Response.” When necessary, refer the reader to the appropriate section of the Turbo EIR for a full explanation of details. This form should be downloaded from the forms site prior to completion and copying. The finished report should be submitted as an attachment to the Turbo EIR. PROCESS ESTABLISHMENT, FILING AND SCHEDULES 1. HAS THE FIRM REGISTERED WITH FDA AND FILED A PROCESS FOR ALL LACFs PROCESSED AT THIS FACILITY, AND FOR FOREIGN FIRMS, ALL PRODUCTS PROCESSED AND SHIPPED TO THE U.S.? – 108.35(c) No YesNo COMMENTS: 2. HAVE PROCESSES BEEN ESTABLISHED FOR ALL LACFs PROCESSED AT THIS FACILITY? – 113.83 COMMENTS: 3. LIST THE FIRM’S PROCESS AUTHORITIES: WHAT ARE THE PROCESS AUTHORITIES’ CREDENTIALS (KNOWLEDGE, TRAINING AND EXPERIENCE) WITH RETORT SYSTEMS, CONTAINERS, PRODUCTS, ETC.? ARE PROCESS AUTHORITIES ACTIVELY INVOLVED IN EVALUATING TEMPERATURE DISTRIBUTION STUDIES, HEAT PENETRATION STUDIES AND DEVIATIONS ANALYSIS? COMMENTS: 4. ARE THE PROCESS AUTHORITIES THE SAME AS THOSE FILED WITH FDA? COMMENTS: 5. DOES THE FIRM HAVE A PROCESS LETTER OR OTHER PROCESS SOURCE DOCUMENTATION LISTING CRITICAL FACTORS NECESSARY TO CONTROL IN THE ATTAINMENT OF COMMERCIAL STERILITY? COMMENTS: 6. DO CRITICAL FACTORS/LIMITS LISTED IN SOURCE DOCUMENTS MATCH CRITICAL FACTORS/LIMITS FOR SELECTED PRODUCTS AND PROCESSES FILED WITH FDA? NOTE – CRITICAL FACTORS MAY EXIST THAT THE FIRM CONTROLS BUT HAVE NOT BEEN IDENTIFIED IN THE PROCESS FILING AND/OR HAS FAILED TO IDENTIFY AND DOES NOT CONTROL. CRITICAL FACTOR LIMITS RECOMMENDED BY THE PROCESS AUTHORITY SHOULD BE EQUAL TO OR GREATER THAN CRITICAL LIMITS FILED WITH FDA. COMMENTS: Yes. YesNo . No Yes. . .No Yes |
| Navigation | Previous Page / Next Page |
| Following Datasheets | UCM071554_1 (7 pages) UCM071562_1 (18 pages) UCM071565_1 (10 pages) UCM071581_1 (9 pages) UCM071587_1 (11 pages) UCM071605_1 (8 pages) UCM071615_1 (11 pages) UCM071640_1 (7 pages) UCM071653_1 (11 pages) UCM071661_1 (11 pages) |
Check in e-portals![]() |
World-H-News Products Extensions Partners Automation Jet Parts |
| Sitemap Folder | group1 group2 group3 group4 group5 group6 group7 group8 group9 group10 group11 group12 group13 group14 group15 group16 group17 group18 group19 group20 group21 group22 group23 group24 group25 group26 group27 group28 group29 group30 group31 group32 group33 group34 group35 group36 group37 group38 group39 group40 group41 group42 group43 group44 group45 group46 group47 group48 group49 group50 group51 group52 group53 group54 group55 group56 group57 group58 group59 group60 group61 group62 group63 group64 group65 group66 group67 group68 group69 group70 group71 group72 group73 group74 group75 group76 group77 group78 group79 group80 group81 group82 group83 group84 group85 group86 group87 group88 group89 group90 group91 group92 group93 group94 group95 group96 group97 group98 group99 group100 Prewious Folder Next Folder |